Overview

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to allow eligible subjects from the parent study, SP925 [NCT00655551] to continue lacosamide and to obtain additional long-term safety data
Phase:
Phase 3
Details
Lead Sponsor:
UCB BIOSCIENCES, Inc.
Treatments:
Lacosamide